Global Intracorporeal Lithotripsy Market Size By Type (Mechanical Lithotripsy, Electrohydraulic Lithotripsy), By Application (Kidney Stones, Biliary Duct Stones), By Region, And Segment Forecasts, 202...

The Global Intracorporeal Lithotripsy Market was valued at USD 1.02 billion in 2023 and is projected to reach USD 1.87 billion by 2031, growing at a CAGR of 7.9% during the forecast period from 2023 to 2031. The rising prevalence of urolithiasis, coupled with increasing adoption of minimally invasive surgical techniques, is driving significant demand for intracorporeal lithotripsy devices. These devices, which fragment urinary stones within the body, are increasingly preferred over extracorporeal methods due to their higher success rates and precision in stone removal.

Drivers:

1. Increasing Incidence of Urolithiasis:

The global burden of kidney stones is rising due to factors such as dietary habits, sedentary lifestyles, and genetic predisposition. This growing prevalence is fueling the demand for effective and minimally invasive treatment methods like intracorporeal lithotripsy.

2. Technological Advancements in Lithotripsy Devices:

Innovations in laser and ultrasonic lithotripsy systems—such as the development of high-frequency holmium lasers and digital ureteroscopes—have improved efficacy, safety, and patient outcomes, propelling market growth.

3. Surge in Geriatric Population:

Older adults are more prone to urinary tract disorders, including kidney stones. As the global elderly population rises, so does the demand for non-invasive and rapid treatment solutions, further accelerating the adoption of intracorporeal lithotripsy.

Restraints:

1. High Cost of Equipment and Procedures:

The advanced technology used in intracorporeal lithotripsy systems leads to high procurement and maintenance costs, limiting adoption, especially in low-resource settings and developing countries.

2. Risk of Complications and Skilled Personnel Requirement:

Despite being minimally invasive, the procedure carries risks such as ureteral injury or infection. Furthermore, it requires skilled urologists and trained professionals, which may not be widely available in some regions.

Opportunity:

1. Rising Healthcare Infrastructure in Emerging Economies:

Countries like India, Brazil, and China are witnessing healthcare modernization and improved access to advanced urology equipment. This trend presents significant growth potential for market players looking to expand in these regions.

2. Increasing Adoption of Disposable Ureteroscopes:

To combat infection risks and improve patient safety, many healthcare institutions are turning to single-use, disposable ureteroscopes. This trend is boosting innovation and investment in the market.

Market by System Type Insights:

The Laser Lithotripsy segment held the largest market share in 2023 and is expected to retain its dominance through 2031. Holmium:YAG lasers are particularly popular due to their effectiveness in fragmenting hard and soft stones with minimal collateral damage. Meanwhile, the Ultrasonic Lithotripsy segment is also gaining traction for its safety profile and effectiveness in larger stone burdens.

Market by End-use Insights:

Hospitals accounted for the largest share in 2023, attributed to the availability of advanced urology departments and skilled medical personnel. However, ambulatory surgical centers (ASCs) are witnessing faster growth due to the increasing number of outpatient procedures, cost-effectiveness, and shorter patient recovery times.

Market by Regional Insights:

North America dominated the global intracorporeal lithotripsy market in 2023, owing to a high prevalence of kidney stone disorders, favorable reimbursement policies, and strong presence of key medical device manufacturers. Asia-Pacific is projected to witness the fastest growth during the forecast period, supported by rising healthcare expenditures, growing medical tourism, and increasing awareness about advanced urological treatments.

Competitive Scenario:

Prominent players in the global market include Boston Scientific Corporation, Olympus Corporation, Karl Storz SE & Co. KG, Dornier MedTech, Cook Medical LLC, Stryker Corporation, EMS Electro Medical Systems S.A., Richard Wolf GmbH, Lumenis Ltd., and HealthTronics, Inc. These companies focus on continuous innovation, strategic partnerships, and geographic expansion to enhance their competitive positioning.

Scope of Work – Global Intracorporeal Lithotripsy Market

Key Market Developments:

2023: Olympus Corporation launched its next-gen single-use ureteroscope with integrated laser compatibility, enhancing safety and procedural precision.

2024: Boston Scientific announced the acquisition of a medtech start-up specializing in compact, portable lithotripsy devices aimed at ambulatory surgical centers.

2025: Dornier MedTech expanded its manufacturing capabilities in Asia to meet the growing demand in emerging markets.

FAQs:

What is the current market size of the Global Intracorporeal Lithotripsy Market?

The market was valued at USD 1.02 billion in 2023.

What is the major growth driver of the Global Intracorporeal Lithotripsy Market?

Rising incidence of urolithiasis and increasing demand for minimally invasive treatments.

Which is the largest region during the forecast period in the Global Intracorporeal Lithotripsy Market?

North America is expected to lead the market throughout the forecast period.

Which segment accounted for the largest market share in Global Intracorporeal Lithotripsy Market?

The Laser Lithotripsy segment held the largest share in 2023.

Who are the key market players in the Global Intracorporeal Lithotripsy Market?

Boston Scientific, Olympus Corporation, Karl Storz, Dornier MedTech, Cook Medical, and Stryker Corporation.